Yes and no.
While pharmaceutical companies within the Fortune 500 universally disclose their collection of personal information by the “enumerated categories” within the CCPA, only 30.77% disclosed what information they share using the CCPA’s enumerated categories.1
For more information and resources about the CCPA visit http://www.CCPA-info.com.
This article is part of a multi-part series published by BCLP to help companies understand and implement the General Data Protection Regulation, the California Consumer Privacy Act and other privacy statutes. You can find more information on the CCPA in BCLP’s California Consumer Privacy Act Practical Guide, and more information about the GDPR in the American Bar Association’s The EU GDPR: Answers to the Most Frequently Asked Questions.
1. BCLP, February 2020: Pharmaceutical Industry Privacy Report.
[View source.]
